Miratashi Yazdi Seyed Amir, Nazar Elham
Department of General Surgery, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Department of Pathology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Iran J Pathol. 2023 Spring;18(2):140-146. doi: 10.30699/ijp.2023.562466.2977. Epub 2023 Jun 20.
BACKGROUND & OBJECTIVE: Lymphovascular tumoral invasion is a typical histopathological feature of gastric carcinomas and supports the recognition of high-risk patients for the recurrence. We aimed to study CD31 expression in diverse subtypes of gastric carcinomas and to show its association with the histopathologic findings of the carcinoma to assess the prognosis.
This cross-sectional study was conducted on 40 established patients with gastric adenocarcinoma from radical gastrectomy. The patients were classified according to the pathology assessments. Tumoral tissues were assessed by immunohistochemical staining for CD31 expression. Malignant behavior was estimated by histopathological evaluations.
CD31 positivity was described in 23 (57.5%) of all evaluated patients. In assessment of CD31 expression and tumor features presented, no significant association between the CD31 expression and patients' age, sex, tumor site, size, grade and stage, subtypes of carcinoma, perineural invasion, and also lymphovascular invasion was found. (>0.05).
Lymphovascular invasion may make valuable additional evidence and may be useful to detect gastric carcinoma patients at high risk for recurrence, who could be candidates for more supplementary therapies. However, in our study, CD31 expression did not show any association with the aggressive histopathologic features of this tumor.
淋巴管肿瘤浸润是胃癌典型的组织病理学特征,有助于识别复发高危患者。我们旨在研究不同亚型胃癌中CD31的表达情况,并显示其与癌组织病理学结果的关联以评估预后。
本横断面研究对40例接受根治性胃切除术的确诊胃腺癌患者进行。根据病理评估对患者进行分类。通过免疫组织化学染色评估肿瘤组织中CD31的表达。通过组织病理学评估估计恶性行为。
在所有评估患者中,23例(57.5%)表现为CD31阳性。在评估CD31表达与所呈现的肿瘤特征时,未发现CD31表达与患者年龄、性别、肿瘤部位、大小、分级和分期、癌的亚型、神经周围浸润以及淋巴管浸润之间存在显著关联(>0.05)。
淋巴管浸润可能提供有价值的额外证据,有助于检测复发高危的胃癌患者,这些患者可能是更多辅助治疗的候选对象。然而,在我们的研究中,CD31表达与该肿瘤的侵袭性组织病理学特征无任何关联。